Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.91 |
| ▸ | BLM | P54132 | 1/20 | 0.91 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.91 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | INPPL1 | O15357 | 2/20 | 0.35 |
| ▸ | INPP5A | Q14642 | 2/20 | 0.35 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.35 |
| ▸ | INPP5B | P32019 | 1/20 | 0.35 |
| ▸ | BTN3A1 | O00481 | 2/20 | 0.35 |
| ▸ | ITPR3 | Q14573 | 3/20 | 0.33 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.33 |
| ▸ | ITPR2 | Q14571 | 1/20 | 0.33 |
| ▸ | ITPR1 | Q14643 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrophosphoric Acid SCHEMBL468667 | 1.00 | FDPS (0.91) | FDPSBLMTDP1CA4CA2 | |
| Pyrophosphoric Acid SCHEMBL8720302 | 1.00 | FDPS (0.91) | FDPSBLMTDP1CA4CA2 | |
| Pyrophosphoric Acid SCHEMBL28281451 | 0.96 | FDPS (0.83) | FDPSBLMTDP1CA4CA2 | |
| Pyrophosphoric Acid SCHEMBL28175665 | 0.96 | FDPS (0.83) | FDPSBLMTDP1CA4CA2 | |
| Pyrophosphoric Acid SCHEMBL27791797 | 0.96 | FDPS (0.83) | FDPSBLMTDP1CA4CA2 | |
| Pyrophosphoric Acid SCHEMBL11417478 | 0.96 | FDPS (0.83) | FDPSBLMTDP1CA4CA2 | |
| Pyrophosphoric Acid SCHEMBL3061797 | 0.96 | FDPS (0.83) | FDPSBLMTDP1CA4CA2 | |
| Pyrophosphoric Acid SCHEMBL9835647 | 0.96 | FDPS (0.83) | FDPSBLMTDP1CA4CA2 | |
| Pyrophosphoric Acid SCHEMBL28168549 | 0.96 | FDPS (0.83) | FDPSBLMTDP1CA4CA2 | |
| Pyrophosphoric Acid SCHEMBL27630418 | 0.96 | FDPS (0.83) | FDPSBLMTDP1CA4CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9044466-B2 | Oral compositions comprising a zinc compound and an anti-microbial agent | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2015-06-02 | — | — | US | claimed |
| EP-2600833-A2 | ORAL COMPOSITIONS COMPRISING A ZINC COMPOUND AND AN ANTI-MICROBIAL AGENT | The Research Foundation for The State University of New York (US) | 2013-06-12 | — | — | EP | claimed |
| WO-2012021415-A2 | ORAL COMPOSITIONS COMPRISING A ZINC COMPOUND AND AN ANTI-MICROBIAL AGENT | RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2012-02-16 | — | — | WO | claimed |
| US-20120034280-A1 | ORAL COMPOSITIONS COMPRISING A ZINC COMPOUND AND AN ANTI-MICROBIAL AGENT | RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2012-02-09 | — | — | US | claimed |
| US-12318463-B2 | Compositions and methods for treating canker sores | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2025-06-03 | — | — | US | disclosed |
| EP-3810067-B1 | METHODS OF INHIBITING MICROBIAL INFECTIONS USING ZINC-CONTAINING COMPOSITIONS | TRIUMPH PHARMACEUTICALS INC (US) | 2025-04-16 | — | — | EP | disclosed |
| US-20250049659-A1 | ORAL COMPOSITIONS AND METHODS OF REDUCING ORAL MALODOR | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK | 2025-02-13 | — | — | US | disclosed |
| US-12053485-B2 | Methods of inhibiting microbial infections using zinc-containing compositions | TRIUMPH PHARMACEUTICALS INC. (US) | 2024-08-06 | — | — | US | disclosed |
| US-20230240951-A1 | COMPOSITION AND METHODS FOR TREATING CANKER SORES | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK | 2023-08-03 | — | — | US | disclosed |
| US-11684555-B2 | Compositions and methods for treating canker sores | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2023-06-27 | — | — | US | disclosed |
| EP-3810067-A1 | METHODS OF INHIBITING MICROBIAL INFECTIONS USING ZINC-CONTAINING COMPOSITIONS | Triumph Pharmaceuticals Inc. (US) | 2021-04-28 | — | — | EP | disclosed |
| CN-112351766-A | Method for inhibiting microbial infections using zinc-containing compositions | 璀昂芬制药公司 | 2021-02-09 | — | — | CN | disclosed |
| US-9138428-B2 | Oral compositions comprising a zinc compound and an anti-microbial agent | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2015-09-22 | — | — | US | disclosed |
| US-9044466-B2 | Oral compositions comprising a zinc compound and an anti-microbial agent | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2015-06-02 | — | — | US | disclosed |
| US-20130164358-A1 | ORAL COMPOSITIONS COMPRISING A ZINC COMPOUND AND AN ANTI-MICROBIAL AGENT | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK | 2013-06-27 | — | — | US | disclosed |
| EP-2600833-A2 | ORAL COMPOSITIONS COMPRISING A ZINC COMPOUND AND AN ANTI-MICROBIAL AGENT | The Research Foundation for The State University of New York (US) | 2013-06-12 | — | — | EP | disclosed |
| WO-2012021419-A2 | ORAL COMPOSITIONS COMPRISING A ZINC COMPOUND | RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2012-02-16 | — | — | WO | disclosed |
| WO-2012021415-A2 | ORAL COMPOSITIONS COMPRISING A ZINC COMPOUND AND AN ANTI-MICROBIAL AGENT | RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2012-02-16 | — | — | WO | disclosed |
| US-20120034280-A1 | ORAL COMPOSITIONS COMPRISING A ZINC COMPOUND AND AN ANTI-MICROBIAL AGENT | RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2012-02-09 | — | — | US | disclosed |
| US-5624906-A | Oral hygiene compositions comprising heteroatom containing alkyl aldonamide compounds | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1997-04-29 | — | — | US | disclosed |